There are multiple GLP-1-class prescription medications used for medical weight loss, and they work slightly differently — the right one depends on your health profile and goals.
Single-receptor GLP-1 medications target the GLP-1 receptor alone. They've been on the market longer, have a longer track record of clinical data, and are often the starting point providers recommend for patients new to this type of treatment.
Dual-receptor GLP-1 medications target both the GLP-1 and GIP receptors — a "dual agonist." Clinical trials have generally shown somewhat greater average weight loss with these compared to single-receptor options, though individual response varies significantly.
Factors that typically influence the choice
- Insurance coverage. Coverage differs by medication and plan — sometimes one is covered and the other isn't, which can be the deciding factor regardless of clinical preference.
- Side effect tolerance. Both medications share similar gastrointestinal side effects (nausea, digestive changes), but individual tolerance varies between the two.
- Prior response. Patients who've tried one without the results they wanted sometimes switch to the other.
- Provider experience and recommendation. Your provider will factor in your labs, health history, and goals — this isn't a decision to make from general information alone.
Neither medication is universally "better" — the right choice depends on your specific health profile, insurance situation, and how your body responds. A licensed provider can walk through which one fits your situation during a consultation.
This content is educational and not a substitute for medical advice. All treatment decisions should be made with a licensed healthcare provider.